Skip to main content

Table 1 Demographic and clinical characteristics of the study sample

From: Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia

Variables

N or Mean ± SD

Male/female (n)

128/109

Smoking(yes/no)

39/198

Age (years)

27.5 ± 7.6

Age of illness onset (years)

25.0 ± 5.0

Disease duration (months)

7.3 ± 4.3

Education (years)

13.2 ± 2.9

Weight (kg)

57.8 ± 8.0

BMI (kg/m2)

20.6 ± 1.9

PANSS-positive

23.0 ± 1.8

PANSS-negative

20.9 ± 1.9

PANSS-general

35.0 ± 3.9

PANSS-total

79.5 ± 4.9

  1. BMI, body mass index; PANSS, the Positive and Negative Syndrome Scale, including positive symptoms, negative symptoms, general psychopathology subscales.